BSE filing, NSE: VINEETLAB. Summary written from the filing by ALFA Finder's alert engine.
Vineet Laboratories Ltd: key numbers
- Share price
- ₹36.80
- Market cap
- ₹70.68 Cr
- Revenue (annual)
- ₹59.40 Cr
- Net profit (annual)
- ₹1.11 Cr
- P/E (TTM)
- 20.2×Sector 41.3×
- Promoter holding
- 5.98%+0.00% QoQ
- FII holding
- 0.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vineet Laboratories Ltd
All →Vineet Laboratories Management Change
Vineet Laboratories appointed SVRL & Co. as statutory auditor after NSVR & Associates resigned. Internal, cost and secretarial auditor changes were also approved.
Vineet Laboratories Board Meeting Date
Vineet Laboratories will hold a board meeting on 4 November 2026 to approve the 10th AGM notice and FY2025-26 Directors' Report. The filing is an advance notice; the agenda is proposed only.
Vineet Laboratories Q1 FY27 Results: Turns Profitable, Net Profit ₹1.5 Cr
Vineet Laboratories Ltd reported revenue from operations of ₹10.4 Cr (+40.5% YoY) and net profit of ₹1.5 Cr for Q1 FY27.
- Key figure
- Net profit ₹1.5 Cr
Vineet Laboratories Board Meeting Date
Vineet Laboratories Limited has scheduled a board meeting on October 26, 2026, to consider and approve standalone financial results for the quarter ended June 30, 2026.
Vineet Laboratories Other Announcement
Vineet Laboratories Ltd has filed its quarterly shareholding pattern as per Regulation 31(1)(b) of SEBI (LODR) Regulations for the quarter ended September 30, 2026.
Vineet Laboratories Management Change
Mr. Vennapusa Premanand Reddy has resigned as a Director of Vineet Laboratories Limited, effective October 14, 2026.
Other other announcement announcements
All →Transchem Other Announcement
Transchem's monitoring agency reports no deviation in warrant proceeds utilisation for the quarter ended September 2026. No material facts were flagged.
Archidply Industries Other Announcement
Archidply Industries disclosed that its RTA, KFin Technologies, is shifting its corporate office to Kokapet, Hyderabad from December 1, 2026. The registered office is unchanged and shareholders should update correspondence addresses.
KEI Industries Other Announcement
Designated person Jashobant Singha Ray pledged 1,500 KEI Industries shares. After the transaction, 10,000 of his 18,000 shares are pledged, with no cash consideration disclosed.
Kansai Nerolac Paints Other Announcement
Kansai Nerolac authorised Pravin Chaudhari, Yash Ahuja and Rukmini Subramanian to determine material events from 1 December 2026. It only lists KMP and contact details.
Glenmark Pharmaceuticals Other Announcement
Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.
Physicswallah Other Announcement
Physicswallah's IPO monitoring report flags a deviation from offer objects for the quarter ended September 30, 2026. The diverted funds were restored on October 30, 2026.